{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:45:42Z","timestamp":1768488342460,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013386","name":"Virginia Mason Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.suc.2020.02.010","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:25:33Z","timestamp":1585761933000},"page":"635-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts"],"prefix":"10.1016","volume":"100","author":[{"given":"Morgan","family":"Bonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio G.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.suc.2020.02.010_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"18","key":"10.1016\/j.suc.2020.02.010_bib2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.010_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5858\/arpa.2015-0314-RA","article-title":"Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts","volume":"140","author":"Kim","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.suc.2020.02.010_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-8703(54)90152-0","volume":"47","author":"Thorson","year":"1954","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.suc.2020.02.010_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/00000658-193506000-00001","article-title":"Adenoma of islet cells with hyperinsulinism: a review","volume":"101","author":"Whipple","year":"1935","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)91343-9","article-title":"A\u00a0glucagonoma syndrome","volume":"304","author":"Mallinson","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.suc.2020.02.010_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00000658-196409000-00013","article-title":"The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases","volume":"160","author":"Ellison","year":"1964","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(77)92113-4","article-title":"Pancreatic somatostatinoma. Clinical features and physiological implications","volume":"309","author":"Larsson","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2020.02.010_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1136\/bmj.282.6278.1767","article-title":"Clinicopathological study of pancreatic and ganglioneuroblastoma tumors secreting vasoactive intestinal polypeptide (VIPomas)","volume":"282","author":"Long","year":"1981","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.suc.2020.02.010_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/MPA.0000000000000920","article-title":"Magnetic resonance imaging of neuroendocrine tumor hepatic metastases: does hepatobiliary phase imaging improve lesion conspicuity and interobserver agreement of lesion measurements?","volume":"46","author":"Morse","year":"2017","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.suc.2020.02.010_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.suc.2020.02.010_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","author":"Sadowski","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.010_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02890062","article-title":"Synaptophysin and chromogranins\/secretogranins\u2013widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis","volume":"58","author":"Wiedenmann","year":"1989","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.suc.2020.02.010_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/02841869109092404","article-title":"Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors","volume":"30","author":"Eriksson","year":"1991","journal-title":"Acta Oncol"},{"key":"10.1016\/j.suc.2020.02.010_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11605-018-04080-1","article-title":"Predictive value of chromogranin A and a pre-operative risk score to predict recurrence after resection of pancreatic neuroendocrine tumors","volume":"23","author":"Fisher","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2016.12.032","article-title":"Aggressive surgical approach to the management of neuroendocrine tumors: a report of 1,000 surgical cytoreductions by a single institution","volume":"224","author":"Woltering","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society","volume":"46","author":"Howe","year":"2017","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.suc.2020.02.010_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","article-title":"Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors","volume":"154","author":"Zaidi","year":"2019","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.suc.2020.02.010_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/DCR.0000000000000574","article-title":"Clinical significance of metastatic lymph nodes in the gut of patients with pure and mixed primary appendiceal carcinoids","volume":"59","author":"Ciarrocchi","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.suc.2020.02.010_bib20","author":"Shah"},{"key":"10.1016\/j.suc.2020.02.010_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suc.2020.02.010_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jamcollsurg.2019.02.050","article-title":"Practice patterns and guideline non-adherence in surgical management of appendiceal carcinoid tumors","volume":"228","author":"Heller","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.surg.2011.02.022","article-title":"Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor","volume":"150","author":"Bettini","year":"2011","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2020.02.010_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1245\/s10434-015-4986-1","article-title":"Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study","volume":"23","author":"Sadot","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.010_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-014-2615-0","article-title":"Surgical resection provides an overall survival benefit for patient with small pancreatic neuroendocrine tumors","volume":"19","author":"Sharpe","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11605-014-2624-z","article-title":"Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications","volume":"19","author":"Curran","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.suc.2020.02.010_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/SLA.0000000000003461","article-title":"A\u00a0novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an international study of 1006 patients","volume":"270","author":"Zaidi","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2036.2006.03130.x","article-title":"Review article: pathogenesis and management of gastric carcinoid tumours","volume":"24","author":"Burkitt","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.suc.2020.02.010_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.amjsurg.2018.12.057","article-title":"Gastric carcinoids: does type of surgery or tumor affect survival?","volume":"217","author":"Crown","year":"2019","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.010_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.suc.2020.02.010_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11605-018-3986-4","article-title":"Surgery provides long-term survival in patients with metastatic neuroendocrine tumors undergoing resection for non-hormonal symptoms","volume":"23","author":"Chakedis","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.010_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.surg.2015.05.040","article-title":"Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy?","volume":"159","author":"Maxwell","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2020.02.010_bib33","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group","volume":"27","author":"Rinke","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.010_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, nonfunctional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study","volume":"387","author":"Yao","year":"2016","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.suc.2020.02.010_bib35","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/1078-0432.CCR-16-2743","article-title":"Long-term efficacy, survival, and safety of [177Lu-DOTA0, Tyr3] octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"23","author":"Brabander","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2020.02.010_bib36","article-title":"SUV of [68Ga]DOTATOC-PET\/CT predicts response probability of PRRT in neuroendocrine tumors","author":"Kratochwil","year":"2014","journal-title":"Mol Imaging Biol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:12:07Z","timestamp":1758539527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610920300232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0039610920300232"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.010","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}